✦ LIBER ✦

Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial

✍ Scribed by B. E. de Galan; S. Zoungas; J. Chalmers; C. Anderson; C. Dufouil; A. Pillai; M. Cooper; D. E. Grobbee; M. Hackett; P. Hamet; S. R. Heller; L. Lisheng; S. MacMahon; G. Mancia; B. Neal; C. Y. Pan; A. Patel; N. Poulter; F. Travert; M. Woodward; for the ADVANCE Collaborative group

Publisher: Springer
Year: 2009
Tongue: English
Weight: 169 KB
Volume: 52
Category: Article
ISSN: 0012-186X
DOI: 10.1007/s00125-009-1484-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral disease and subsequent cardiovascul

Oral disease and subsequent cardiovascular disease in people with type 2 diabetes: a prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial

✍ Q. Li; J. Chalmers; S. Czernichow; B. Neal; B. A. Taylor; S. Zoungas; N. Poulter 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 145 KB

Study Rationale and Design of ADVANCE: A

Study Rationale and Design of ADVANCE: Action in Diabetes and Vascular disease – preterax and diamicron MR controlled evaluation

✍ ; ADVANCE Management Committee 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 58 KB

The Framingham and UK Prospective Diabet

The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study

✍ A. P. Kengne; A. Patel; S. Colagiuri; S. Heller; P. Hamet; M. Marre; C. Y. Pan; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 217 KB

Proteinuria modifies the effects of phys

Proteinuria modifies the effects of physical activity on total and cardiovascular disease mortality rates in patients with type 2 diabetes

✍ T. Vepsäläinen; M. Soinio; S. Lehto; A. Juutilainen; M. Laakso; T. Rönnemaa 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 95 KB

Metabolic control and vascular diseases

Metabolic control and vascular diseases under oral antidiabetic drug versus insulin therapy and/or diet alone during the first year of hemodialysis in type 2 diabetic patients with ESRD

✍ Georg Biesenbach; Gert Bodlaj; Stephan Ebner; Peter Biesenbach; Herwig Pieringer 📂 Article 📅 2010 🏛 Springer Netherlands 🌐 English ⚖ 198 KB